Inspection report spot checks may be kick start GMP MRA talks, PhRMA suggests.
Executive Summary
EUROPEAN INSPECTION REPORT SPOT CHECKS BY FDA COULD BREAK U.S.-EU DEADLOCK in developing a mutual recognition agreement, Pharmaceutical Research & Manufacturers of America Deputy VP-International Richard Saul suggested at an Oct. 30 public exchange meeting on a Good Manufacturing Practices MRA between the U.S. and the European Union.